Ligand Pharmaceuticals Joins Elite List Of Stocks With 95-Plus Composite RatingInvestors Business Daily • 03/12/21
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/03/21
Ligand Partner Travere Therapeutics Announces Achievement of Interim Proteinuria Endpoint in the Ongoing Phase 3 DUPLEX Study of Sparsentan in Focal Segmental GlomerulosclerosisBusiness Wire • 02/02/21
Levi & Korsinsky LLP, National Class Action Law Firm, Announces Class Action Investigation Against Robinhood and Other Brokers on Behalf of Investors in Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)Newsfile Corp • 01/29/21
These 10 highly shorted stocks are soaring as Reddit traders wage war against top Wall Street hedge fundsBusiness Insider • 01/27/21
Top-Rated Stocks: Ligand Pharmaceuticals Sees Composite Rating Climb To 97Investors Business Daily • 01/20/21
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen's Discovery Technology to Target Neurological DisordersBusiness Wire • 12/21/20
Ligand (LGND) Up 3.4% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/29/20
Ligand Announces Clinical and Regulatory Progress by Multiple Partners with OmniAb® AntibodiesBusiness Wire • 11/23/20